PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > Non Clinical Profile : Unlicensed Medicines
Non Clinical Profile : Unlicensed Medicines
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 September 2018
Guidelines (National)
01 December 2018
Guidelines (National)
Letter template (to specialist)
01 March 2021
Webpage
01 November 2023
Other Drugs
Committee Recommendations
Date
Committee Name
Narrative
08 September 2021
Surrey Heartlands Medicines Safety Committee (MSC)
The Neonatal & Paediatric Pharmacist Group (NPPG) and the Royal College of Paediatrics and Child Health (RCPCH) have published recommendations for choosing unlicensed oral liquids for children.
The advice has been reviewed and agreed by the Medicines safety Group and a weblink has been provided below.
04 April 2018
Surrey Medicines Commissioners Group
The Medicines Commissioners Group agreed to extend the review date for the Unlicensed Medicines Guide - below
The review date has been extended to Sep 2018
06 September 2017
Surrey Medicines Commissioners Group
The MCG endorsed the following updates to the Specials advice on the PAD:
PrescQIPP Specials Optimisation Tool (SPOT) - Sep 2016 has been locally adopted and replaces the previous version.
The Royal Pharmaceutical Society guidelines and professional standards for prescribing, procurement and supply of specials - both provided below
Some common unlicensed medicines have been included within Part VIIIB of the Drug Tariff. Prices and formulations vary so prescribers should check the Tariff for the latest information and the most cost-effective way of prescribing. A link to the Drug Tariff is provided at the bottom of the page.
Information and local recommendations in relation to a number of specific unlicensed medicines can be found by searching the PAD by drug name.
04 March 2015
Surrey Medicines Commissioners Group
An updated Guideline for "Crushing Medicines and the Use of Specials" was presented to, and agreed for use by, the Surrey Medicines Commissioning Group.
See document below